← Back to Search

Time-Restricted Eating vs Traditional Dieting for Obesity (NY-TREAT Trial)

N/A
Recruiting
Led By Blandine Laferrère, M.D., Ph.D.
Research Sponsored by Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
- Diagnosis of dyslipidemia on stable regimen
- Diagnosis of hypertension on stable medication regimen
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0, 3,12 months
Awards & highlights

NY-TREAT Trial Summary

This trial will compare the effects of two different types of diets on weight loss, metabolism, and circadian biology in adults who are overweight or obese. The first diet is a time-restricted diet, where people eat whatever they want but only during a 10-hour window each day. The second diet is a more traditional diet where people eat whatever they want but try to limit their overall daily calorie intake. The investigators hypothesize that the time-restricted diet will be more effective than the traditional diet in terms of weight loss and improvement of metabolism.

Who is the study for?
This trial is for English-speaking adults aged 50-75 in the NYC area, with a BMI of 25-45 and conditions like hypertension, prediabetes or type 2 diabetes controlled by diet/metformin. Participants should have stable weight, eat breakfast habitually, and own a smartphone. Exclusions include smokers, those with severe diseases or sleep disorders, previous bariatric surgery patients, heavy alcohol consumers, and certain medication users.Check my eligibility
What is being tested?
The study compares two eating patterns to improve heart health and metabolism in overweight individuals: Time Restricted Eating (TRE) where participants eat within a 10-hour window versus their usual pattern (HABIT) of eating over a span of about 13 hours daily. The focus is on whether TRE can better reduce cardiovascular risks.See study design
What are the potential side effects?
While not explicitly listed in the provided information, potential side effects may include hunger pangs during fasting periods with TRE; changes in energy levels; headaches; dizziness due to changes in meal timing which could affect blood sugar levels.

NY-TREAT Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with dyslipidemia and am on a stable treatment plan.
Select...
I have high blood pressure and am on a stable medication plan.
Select...
I usually sleep for 6 hours, wake up after 5 AM but before 11 AM, and go to bed before 2 AM.
Select...
I am between 50 and 75 years old.

NY-TREAT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0, 3,12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 0, 3,12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adherence
Body weight
Energy intake
+5 more
Secondary outcome measures
Diet composition by ASA24
Free fatty acids (FFA)
Inflammation markers
+6 more

NY-TREAT Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: TRE GroupExperimental Treatment1 Intervention
Participants randomized to TRE will reduce their eating window to a self-selected eating window (≤10-h).
Group II: HABIT GroupActive Control1 Intervention
Participants randomized to the HABIT group will maintain their habitual eating schedule (≥13-h).

Find a Location

Who is running the clinical trial?

National Institute on Aging (NIA)NIH
1,675 Previous Clinical Trials
28,020,873 Total Patients Enrolled
43 Trials studying Obesity
12,698 Patients Enrolled for Obesity
Columbia UniversityLead Sponsor
1,433 Previous Clinical Trials
2,447,207 Total Patients Enrolled
41 Trials studying Obesity
5,994 Patients Enrolled for Obesity
New York UniversityOTHER
226 Previous Clinical Trials
314,065 Total Patients Enrolled
6 Trials studying Obesity
3,018 Patients Enrolled for Obesity

Media Library

HABIT Clinical Trial Eligibility Overview. Trial Name: NCT04465721 — N/A
Obesity Research Study Groups: HABIT Group, TRE Group
Obesity Clinical Trial 2023: HABIT Highlights & Side Effects. Trial Name: NCT04465721 — N/A
HABIT 2023 Treatment Timeline for Medical Study. Trial Name: NCT04465721 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are any openings currently available in this research study?

"Affirmative, the clinical trial is actively recruiting. As shown on clinicaltrials.gov, it was initially posted in May 2021 and has been consistently updated up until August 2022. The required patient pool stands at 52 individuals across a single site."

Answered by AI

How many volunteers have registered for this experiment?

"Affirmative. Clinicaltrials.gov contains evidence that this trial is recruiting participants, which began on May 26th 2021 and was last updated August 3rd 2022. This medical study will accept no more than 52 volunteers at a single site."

Answered by AI

Does this research accept individuals older than 50 years of age?

"This trial is seeking out individuals between the ages of 50 and 70."

Answered by AI

What benefits is this trial seeking to confer?

"This research trial will assess glucose variability over a 0, 3 and 12 month period as the primary outcome. Supplementary outcomes include Insulinogenic Index (calculated by insulin/glucose AUC during OGTT), Lipid Profile (measured from fasting blood sample) and Free Fatty Acids (FFA; measured from fasting blood samples)."

Answered by AI

Who meets the qualifications to partake in this medical research?

"This trial requires 52 people aged between 50 and 70 who possess impaired glucose tolerance. Additionally, they must have a BMI in the range of 25-45 kg/m2, diagnosis of hypertension on stable medication regimen, blood pressure >120/>80 mmHg, A diagnosis of dyslipidemia on stable regimen with triglycerides 150 mg/dL; waist circumference men: >102 cm (>40 inches); women >88 cm (>35 inches), access to either an iPhone or Android smart phone, adherence to logging for at least 70% days (with 2 or more log entries per day spaced by 5 hours minimum) as well as HDL"

Answered by AI

Who else is applying?

What state do they live in?
New York
What site did they apply to?
Columbia University
What portion of applicants met pre-screening criteria?
Met criteria
~11 spots leftby Jan 2025